CRISPR Therapeutics AG【CRSP】 営業利益の推移

機能の使い方
(単位:千ドル) 営業利益 前年比(%)
1Q25 -148,424 +5.6%
3Q24 -110,130 -16.8%
2Q24 -151,260 +58.8%
1Q24 -140,587 +118.0%
3Q23 -132,411 -27.4%
2Q23 -95,223 -48.0%
1Q23 -64,487 -63.4%
3Q22 -182,388 +41.6%
2Q22 -183,260 -124.0%
1Q22 -175,972 +53.6%
3Q21 -128,849 +39.4%
2Q21 762,618 -1045.1%
1Q21 -114,543 +55.7%
4Q20 -107,761 -1081.2%
3Q20 -92,399 -166.4%
2Q20 -80,689 +46.8%
1Q20 -73,586 +52.0%
4Q19 10,983 -124.3%
3Q19 139,163 -381.5%
2Q19 -54,983 +47.5%
1Q19 -48,423 +79.4%
4Q18 -45,228 -4753.1%
3Q18 -49,432 +109.7%
2Q18 -37,286 +75.0%
1Q18 -26,997 +30.1%
4Q17 972 -103.8%
3Q17 -23,570 +61.3%
2Q17 -21,306 -
1Q17 -20,744 -
4Q16 -25,310 -
3Q16 -14,610 -